114 related articles for article (PubMed ID: 16895705)
1. [The evolution of the hypervariable region-1 of hepatitis C virus may predict liver fibrosis outcome after renal transplantation].
Kamar N; Rostaing L; Selves J; Sandres-Saune K; Alric L; Durand D; Izopet J
Nephrol Ther; 2005 Dec; 1(6):345-54. PubMed ID: 16895705
[TBL] [Abstract][Full Text] [Related]
2. Does cyclosporine have a beneficial effect on the course of chronic hepatitis C infection after renal transplantation?
Kamar N; Selves J; Sandres-Saune K; Durand D; Izopet J; Rostaing L
Transplant Proc; 2006 Jun; 38(5):1329-32. PubMed ID: 16797294
[TBL] [Abstract][Full Text] [Related]
3. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation.
Kamar N; Rostaing L; Selves J; Sandres-Saune K; Alric L; Durand D; Izopet J
Am J Transplant; 2005 Jul; 5(7):1704-12. PubMed ID: 15943629
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients.
Izopet J; Rostaing L; Sandres K; Cisterne JM; Pasquier C; Rumeau JL; Duffaut M; Durand D; Puel J
J Infect Dis; 2000 Mar; 181(3):852-8. PubMed ID: 10720504
[TBL] [Abstract][Full Text] [Related]
5. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4.
Wali MH; Heydtmann M; Harrison RF; Gunson BK; Mutimer DJ
Liver Transpl; 2003 Aug; 9(8):796-804. PubMed ID: 12884191
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection.
Matos CA; Perez RM; Lemos LB; Medina-Pestana JO; Lanzoni VP; Alberto FL; Moreira ES; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):653-7. PubMed ID: 17625434
[TBL] [Abstract][Full Text] [Related]
7. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
[TBL] [Abstract][Full Text] [Related]
8. Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.
Bonnard P; Lescure FX; Amiel C; Guiard-Schmid JB; Callard P; Gharakhanian S; Pialoux G
J Viral Hepat; 2007 Nov; 14(11):806-11. PubMed ID: 17927617
[TBL] [Abstract][Full Text] [Related]
9. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
Sadamori H; Yagi T; Iwagaki H; Matsuda H; Shinoura S; Umeda Y; Ohara N; Yanai H; Ogino T; Tanaka N
J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
[TBL] [Abstract][Full Text] [Related]
11. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
12. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.
Hanouneh IA; Feldstein AE; McCullough AJ; Miller C; Aucejo F; Yerian L; Lopez R; Zein NN
Liver Transpl; 2008 Sep; 14(9):1287-93. PubMed ID: 18756451
[TBL] [Abstract][Full Text] [Related]
13. The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study.
Delladetsima I; Psichogiou M; Sypsa V; Psimenou E; Kostakis A; Hatzakis A; Boletis JN
Am J Kidney Dis; 2006 Feb; 47(2):309-16. PubMed ID: 16431260
[TBL] [Abstract][Full Text] [Related]
14. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.
Katz LH; Mor E; Brown M; Bar-Nathan N; Shaharabani E; Sulkes J; Pappo O; Tur-Kaspa R; Ben-Ari Z
Clin Transplant; 2006; 20(4):465-70. PubMed ID: 16842523
[TBL] [Abstract][Full Text] [Related]
15. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
Sulkowski MS; Mehta SH; Torbenson MS; Higgins Y; Brinkley SC; de Oca RM; Moore RD; Afdhal NH; Thomas DL
AIDS; 2007 Oct; 21(16):2209-16. PubMed ID: 18090048
[TBL] [Abstract][Full Text] [Related]
16. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
[TBL] [Abstract][Full Text] [Related]
17. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.
Samonakis DN; Cholongitas E; Thalheimer U; Kalambokis G; Quaglia A; Triantos CK; Mela M; Manousou P; Senzolo M; Dhillon AP; Patch D; Burroughs AK
Liver Transpl; 2007 Sep; 13(9):1305-11. PubMed ID: 17763383
[TBL] [Abstract][Full Text] [Related]
18. Evolution of hepatitis C virus quasispecies in renal transplant patients with de novo glomerulonephritis.
Kamar N; Rostaing L; Boulestin A; Sandres K; Dubois M; Ribes D; Modesto A; Durand D; Izopet J
J Med Virol; 2003 Apr; 69(4):482-8. PubMed ID: 12601755
[TBL] [Abstract][Full Text] [Related]
19. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
[TBL] [Abstract][Full Text] [Related]
20. Investigation of possible clinical and laboratory predictors of liver fibrosis in hemodialysis patients infected with hepatitis C virus.
Boyacioğlu S; Gür G; Yilmaz U; Korkmaz M; Demirhan B; Bilezikçi B; Ozdemir N
Transplant Proc; 2004; 36(1):50-2. PubMed ID: 15013298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
